Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India

被引:33
作者
Joglekar, N.
Joshi, S.
Kakde, M.
Fang, G.
Cianciola, M.
Reynolds, S.
Mehendale, S.
机构
[1] Indian Council Med Res, Natl AIDS Res Inst, Pune 411026, Maharashtra, India
[2] NIAID, NIH, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2007年 / 19卷 / 06期
关键词
D O I
10.1080/09540120601133576
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Acceptability of PRO2000 Gel, a candidate vaginal microbicide, among participants of its Phase I safety study in Pune, India is reported here. Forty-two eligible women were enrolled in a study requiring twice daily intra-vaginal product use for 14 consecutive days between menses. Acceptability was assessed at study exit through structured questionnaires among 41 participants who completed the product use, and five focus group discussions involving 31 study participants. The participants generally liked the product (40/41, 97.2%), especially its colour (40, 97.2%) and consistency (35, 85.3%). Thirty-four participants reported sexual intercourse within one hour of product use, at least once during the study period and sexual pleasure was reported to be better or unaffected among (30, 88.2%) participants. Nearly 70% did not like its smell and mentioned preference for a product that would be unnoticeable to the male partner. Participating women were concerned about privacy in usage and storage of the product. Acceptability of PRO2000 vaginal gel was good, but its smell will have to be improved. Counselling to address women's concerns about privacy and storage will be crucial. Women's preference for unnoticeable product indicates their empowerment and willingness to accept female-controlled options for HIV prevention.
引用
收藏
页码:817 / 821
页数:5
相关论文
共 15 条
  • [1] Acceptability of a microbicide among women and their partners in a 4-country phase I trial
    Bentley, ME
    Fullem, AM
    Tolley, EE
    Kelly, CW
    Jogelkar, N
    Srirak, N
    Mwafulirwa, L
    Khumalo-Sakutukwa, G
    Celentano, DD
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (07) : 1159 - 1164
  • [2] Elias CJ, 1996, AIDS, V10, pS43
  • [3] *INT WORK GROUP VA, 1996, AIDS, V10, pS1
  • [4] Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women
    Mayer, KH
    Karim, SA
    Kelly, C
    Maslankowski, L
    Rees, H
    Profy, AT
    Day, J
    Welch, J
    Rosenbergh, Z
    [J]. AIDS, 2003, 17 (03) : 321 - 329
  • [5] Moon Martha W, 2002, J Transcult Nurs, V13, P19, DOI 10.1177/104365960201300104
  • [6] The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial
    Morrow, K
    Rosen, R
    Richter, L
    Emans, A
    Forbes, A
    Day, J
    Morar, N
    Maslankowski, L
    Profy, AT
    Kelly, C
    Karim, SSA
    Mayer, KH
    [J]. JOURNAL OF WOMENS HEALTH, 2003, 12 (07) : 655 - 666
  • [7] *QSR INT PVT LTD, 2002, QSR N6 REL V 6 0
  • [8] India's response to the HIV epidemic
    Rao, JVRP
    Ganguly, NK
    Mehendale, SM
    Bollinger, RC
    [J]. LANCET, 2004, 364 (9442) : 1296 - 1297
  • [9] A framework for examining the sustained acceptability of microbicides
    Severy, LJ
    Tolley, E
    Woodsong, C
    Guest, G
    [J]. AIDS AND BEHAVIOR, 2005, 9 (01) : 121 - 131
  • [10] Shiva M, 1999, Health Millions, V25, P36